Gonococcal infections and emergence of gonococcal decreased susceptibility to cephalosporins in France, 2001 to 2012.
暂无分享,去创建一个
B. Berçot | E. Cambau | P. Sednaoui | A. Goubard | G. La Ruche | C. Semaille | G La Ruche | A Goubard | B Bercot | E Cambau | C Semaille | P Sednaoui | G. L. Ruche
[1] J. Wasserheit,et al. The emerging threat of untreatable gonococcal infection. , 2012, The New England journal of medicine.
[2] Josefina Ayats,et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. , 2012, The Journal of antimicrobial chemotherapy.
[3] A Coulter,et al. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. , 1993, BMJ.
[4] G Stanek,et al. Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. , 2011, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[5] Qingxia Chen,et al. Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. , 2011, The Journal of infectious diseases.
[6] Kate E. Jones,et al. Impacts of biodiversity on the emergence and transmission of infectious diseases , 2010, Nature.
[7] R. F. S. C. G. J. D. N. C. Worsham,et al. Resurgent bacterial sexually transmitted disease among men who have sex with men--King County, Washington, 1997-1999. , 1999, MMWR. Morbidity and mortality weekly report.
[8] A. Halling,et al. Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers , 2006, European Journal of Clinical Microbiology and Infectious Diseases.
[9] U. Buchholz,et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[10] B. Twisselmann,et al. Surveillance of Lyme borreliosis in Germany, 1999 , 2001 .
[11] S. Wisniewski,et al. Interim Adjusted Estimates of Seasonal Influenza Vaccine Effectiveness — United States, February 2013 , 2013, MMWR. Morbidity and mortality weekly report.
[12] W. Rakowicz,et al. Lyme disease in the United Kingdom , 2013, Postgraduate Medical Journal.
[13] Fabrice Carrat,et al. INFLUENZA BURDEN OF ILLNESS: ESTIMATES FROM A NATIONAL PROSPECTIVE SURVEY OF HOUSEHOLD CONTACTS IN FRANCE , 2002, Archives of internal medicine.
[14] M. Cartter,et al. Effect of Surveillance Method on Reported Characteristics of Lyme Disease, Connecticut, 1996–2007 , 2012, Emerging infectious diseases.
[15] E. Lindgren,et al. Effects of Climate Change on Ticks and Tick-Borne Diseases in Europe , 2009, Interdisciplinary perspectives on infectious diseases.
[16] M. Unemo,et al. 2012 European guideline on the diagnosis and treatment of gonorrhoea in adults , 2013, International journal of STD & AIDS.
[17] U. Buchholz,et al. Comparison of Shedding Characteristics of Seasonal Influenza Virus (Sub)Types and Influenza A(H1N1)pdm09; Germany, 2007–2011 , 2012, PloS one.
[18] Anne Gallay,et al. A survey of primary care physician practices in antibiotic prescribing for the treatment of uncomplicated male gonoccocal urethritis , 2011, BMC family practice.
[19] D. Lipsker,et al. How accurate is a clinical diagnosis of erythema chronicum migrans? Prospective study comparing the diagnostic accuracy of general practitioners and dermatologists in an area where lyme borreliosis is endemic. , 2004, Archives of dermatology.
[20] A. N. Robertson,et al. Effectiveness of seasonal 2012/13 vaccine in preventing laboratory-confirmed influenza infection in primary care in the United Kingdom: mid-season analysis 2012/13 , 2013 .
[21] M. Meltzer,et al. Economic Impact of Lyme Disease , 2006, Emerging infectious diseases.
[22] P. Mead,et al. Surveillance for Lyme disease--United States, 1992-2006. , 2008, Morbidity and mortality weekly report. Surveillance summaries.
[23] J. Iredell,et al. Rapid semi-automated quantitative multiplex tandem PCR (MT-PCR) assays for the differential diagnosis of influenza-like illness , 2010, BMC infectious diseases.
[24] V. van Casteren,et al. Incidence and management of presumption of Lyme borreliosis in Belgium: recent data from the sentinel network of general practitioners , 2012, European Journal of Clinical Microbiology and Infectious Diseases.
[25] D. Skowronski,et al. Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses , 2014, PloS one.
[26] D. Whiley,et al. Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods. , 2009, Journal of medical microbiology.
[27] S. Lindstrom,et al. Design and Performance of the CDC Real-Time Reverse Transcriptase PCR Swine Flu Panel for Detection of 2009 A (H1N1) Pandemic Influenza Virus , 2011, Journal of Clinical Microbiology.
[28] Nicholas S. Kelley,et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.
[29] C. Semaille,et al. Épidémiologie actuelle des infections sexuellement transmissibles bactériennes en France , 2013 .
[30] A. Flahault,et al. Virtual surveillance of communicable diseases: a 20-year experience in France , 2006, Statistical methods in medical research.
[31] Makoto Ohnishi,et al. Ceftriaxone-Resistant Neisseria gonorrhoeae, Japan , 2011, Emerging infectious diseases.
[32] A. Flahault,et al. Lyme disease in France: a primary care-based prospective study , 2005, Epidemiology and Infection.
[33] J. Halperin,et al. The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[34] David N. Reshef,et al. Factors Related to Increasing Prevalence of Resistance to Ciprofloxacin and Other Antimicrobial Drugs in Neisseria gonorrhoeae, United States , 2012, Emerging infectious diseases.
[35] D. Livermore,et al. Decreased susceptibility to cephalosporins among gonococci: data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales, 2007-2011. , 2013, The Lancet. Infectious diseases.
[36] G. Poggensee,et al. Epidemiological situation of Lyme borreliosis in Germany: Surveillance data from six Eastern German States, 2002 to 2006 , 2008, Parasitology Research.
[37] J. Desenclos,et al. Increase of Neisseria gonorrhoeae Ciprofloxacin Resistance in France in 2001–2003 , 2006, Sexually transmitted diseases.
[38] P. Sednaoui,et al. Gonorrhoea Surveillance System in France: 1986–2000 , 2004, Sexually transmitted diseases.
[39] S. Subak,et al. Effects of climate on variability in Lyme disease incidence in the northeastern United States. , 2003, American journal of epidemiology.
[40] A. Nicoll,et al. Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe? , 2002, BMJ : British Medical Journal.
[41] M. Unemo,et al. Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future , 2011, Annals of the New York Academy of Sciences.
[42] M. Unemo,et al. High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure , 2011, Antimicrobial Agents and Chemotherapy.
[43] J. Ioannidis,et al. Effectiveness and harms of seasonal and pandemic influenza vaccines in children, adults and elderly , 2012, Human vaccines & immunotherapeutics.
[44] M. Unemo,et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[45] M. Yasuda,et al. Threat to Cefixime Treatment for Gonorrhea , 2007, Emerging infectious diseases.
[46] A Stary,et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[47] M. Neteler,et al. Lyme borreliosis in Europe. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[48] L. Stjernberg,et al. Effect of gender on clinical and epidemiologic features of Lyme borreliosis. , 2007, Vector borne and zoonotic diseases.
[49] I. Martin,et al. Neisseria gonorrhoeae treatment failure and susceptibility to cefixime in Toronto, Canada. , 2013, JAMA.
[50] I. Martin,et al. Cephalosporin and Azithromycin Susceptibility in Neisseria gonorrhoeae Isolates by Site of Infection, British Columbia, 2006 to 2011 , 2013, Sexually transmitted diseases.
[51] W. Paget,et al. Trends in gonorrhoea in nine western European countries, 1991–6 , 2000, Sexually transmitted infections.
[52] A. Valleron,et al. Attitude of French general practitioners to the public health surveillance of communicable diseases. , 1995, International journal of epidemiology.
[53] John W Tapsall,et al. Antibiotic resistance in Neisseria gonorrhoeae. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[54] R. Webby,et al. Implementing hospital-based surveillance for severe acute respiratory infections caused by influenza and other respiratory pathogens in New Zealand. , 2014, Western Pacific surveillance and response journal : WPSAR.
[55] G. Hogg,et al. Failure of 500 mg of ceftriaxone to eradicate pharyngeal gonorrhoea, Australia. , 2013, The Journal of antimicrobial chemotherapy.
[56] G. Stanek,et al. Epidemiology of European Lyme borreliosis. , 1998, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[57] K. Holmes,et al. Neisseria gonorrhoeae Antimicrobial Resistance Among Men Who Have Sex With Men and Men Who Have Sex Exclusively With Women: The Gonococcal Isolate Surveillance Project, 2005–2010 , 2013, Annals of Internal Medicine.
[58] V Demicheli,et al. Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review , 2005, The Lancet.
[59] H. Wilking,et al. Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012. , 2014, Ticks and tick-borne diseases.
[60] J. Takkinen,et al. Lyme borreliosis: Europe-wide coordinated surveillance and action needed? , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[61] Michael Haber,et al. The case test-negative design for studies of the effectiveness of influenza vaccine. , 2013, Vaccine.
[62] Harish Nair,et al. Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis , 2011, The Lancet.
[63] M. Unemo,et al. Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. , 2013, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.